Every one of those 1 sits in a single category, markets. OTC Markets Group is most often covered alongside American Depositary Receipt, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Finance story that mention OTC Markets Group, all published on September 26, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about OTC Markets Group
Every one of those 1 sits in a single category, markets. OTC Markets Group is most often covered alongside American Depositary Receipt, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Finance story that mention OTC Markets Group, all published on September 26, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 9 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering OTC Markets Group. Shared-story counts are live from our verified record — not editorial picks.
MetaOptics announces establishment of a sponsored Level 1 ADR programme on OTCQX with J.P. Morgan as depositary bank. No capital raising or new share issuance.
CES 2026 participation
MetaOptics returns to CES in 2026, continuing U.S. engagement with partners, customers, and investors.
Catalist listing on SGX-ST
MetaOptics completes its listing on the Catalist board of the Singapore Exchange, establishing its home market listing.
CES 2025 participation
MetaOptics participates in CES 2025, building early U.S. industry visibility prior to its ADR programme.
Singapore-listed MetaOptics launches a Level 1 ADR on OTCQX with J.P. Morgan as depositary bank, giving U.S. investors access without issuing new shares. The programme involves no capital raise and is expected to have no material impact on existing shareholders.